中国经济网北京2月10日讯 联盛化学(301212.SZ)昨晚披露关于公司控股股东及其一致行动人减持股 份预披露的公告称，公司的控股股东联盛化学集团有限公司（以下简称"联盛集团"）及其一致行动人台 州市高盛投资合伙企业（有限合伙）（以下简称"台州高投"）计划自公告披露之日起15个交易日后的3 个月内以集中竞价交易方式和大宗交易方式减持公司股份。 直接持有公司股份57,000,000股（占公司总股本比例52.78%）的控股股东联盛集团和直接持有公司 股份5,000,000股（占公司总股本比例4.63%）的一致行动人台州高投计划以集中竞价交易方式和大宗交 易方式减持其持有的公司股份合计不超过3,240,000股（占公司总股本比例3%）。其中，以集中竞价交 易方式减持的，在任意连续90个自然日内，减持股份的总数合计不得超过公司股份总数的1%；通过大 宗交易方式减持的，在任意连续90个自然日内，减持股份的总数合计不得超过公司股份总数的2%。 按照昨日收盘价30.97元计算，联盛集团及其一致行动人台州高投本次拟套现约1亿元。 联盛化学表示，截至公告披露日，公司不存在破发、破净情形，最近三年累计现金分红金额未低于 最近三 ...

Group 1 - Fangda Carbon plans to acquire 100% equity of Tianjin Tongda Huanyu Logistics Co., Ltd. for 319 million yuan [1] - Xiamen Tungsten intends to acquire 39% equity of Jiujiang Dadi Mining Development Co., Ltd. and has signed an intention agreement with a transferor [6] - Wenkai Co. has won a bid for a landscape project worth 50.8162 million yuan [7] Group 2 - Changchun High-tech's subsidiary Jin Sai Pharmaceutical received approval for a clinical trial application for GenSci136, a treatment for IgA nephropathy [3] - China National Pharmaceutical has received drug registration certificates for fumaric acid volnoral tablets, used for treating reflux esophagitis [12] - Zhenhua Group plans to issue convertible bonds not exceeding 1.2 billion yuan [26] Group 3 - CSG Holding's stock may undergo a control change due to share pledge judicial transfer [30] - Ningbo Yunsheng plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [19] - Keda Guochuang's controlling shareholder intends to transfer 5% of the company's shares through an agreement [28] Group 4 - A number of companies, including Finer Pharma, Yixing Guoyuan Investment, and others, have announced plans to reduce their shareholdings by various percentages [2][4][9][11][15][16][20][21][22][23][25][29] - Highweida plans to repurchase shares worth 30 to 35 million yuan [17] - ST Zhongzhu is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [24] Group 5 - A number of companies, including Jiekang Equipment and others, have faced legal issues or penalties [27][40] - Aclaris Therapeutics has clarified that reports regarding its robotic products entering mass production were misinterpreted [41]

方大炭素公告称，拟收购天津通达环宇物流有限公司100%股权，交易价格为3.19亿元，有助于公司优 化库存管理，整合公司及子公司物流环节的管控效率与稳定性，提升公司抗风险能力，降低储运及物流 成本。 厦门钨业：拟收购九江大地矿业开发有限公司39%股权 厦门钨业公告称，公司与北京尚达信投资有限公司签署协议，尚达信拟向公司转让其持有的九江大地矿 业开发有限公司39%股权，公司有意向收购该股权并支付意向金2800万元，收购部分股权并控股九江大 地的整体交易方案尚需与标的公司及其他股东进一步协商确定。 埃夫特：拟购买盛普股份100%股份 每经记者｜王帆 每经编辑｜程鹏 董兴生 记者|王帆 编辑|程鹏 董兴生 杜恒峰 校对|陈柯名 并购重组 方大炭素：拟以3.19亿元收购天津通达环宇物流有限公司100%股权 崧盛股份：股东拟合计减持不超5%公司股份 崧盛股份公告称，控股股东、实际控制人王宗友、田年斌计划合计减持公司股份不超过3%；董事兼副 总经理邹超洋计划减持不超0.37%；股东崧盛投资计划减持不超1.63%。 风险事项 埃夫特发布交易预案称，公司拟通过发行股份及支付现金的方式向至骞实业等10名交易对方购买其持有 的盛普 ...

Group 1 - The controlling shareholder of Bowei Alloy plans to increase its stake in the company by 100 million to 150 million yuan [1] - The actual controller and directors of Congsheng Co. intend to reduce their holdings by no more than 5% of the company's shares [1] - Yinbei Investment of Senba Sensor plans to reduce its stake by no more than 3% of the company's shares [1] Group 2 - The controlling shareholder and its concerted parties of Liansheng Chemical plan to reduce their holdings by no more than 3% of the company's shares [1] - A shareholder of ST Zhongzhu intends to reduce its stake by no more than 3% of the company's shares [1] - Shareholders of Youde Precision (rights protection) plan to collectively reduce their holdings by no more than 3% of the company's shares [1] Group 3 - Shareholder Finer of Xuantai Pharmaceutical plans to reduce its stake by no more than 2% of the company's shares [1] - A shareholder of Far East Co. intends to reduce its holdings by no more than 1.5% of the company's shares [1] - A shareholder of Zhongzhou Special Materials plans to reduce its stake by no more than 1.4% of the company's shares [1] Group 4 - Qianhai Jin控 plans to reduce its stake in GCL-Poly Energy by no more than 1.01% of the company's shares [1] - The controlling shareholder of Keda Technology intends to reduce its holdings by no more than 1% of the company's shares [1] - Yulong Venture Capital plans to reduce its stake in Haiguo Co. by no more than 0.9965% of the company's shares [1] Group 5 - Shareholders of Lian Technology plan to collectively reduce their holdings by no more than 0.96% of the company's shares [1] - The controlling shareholder of Teda Co. intends to reduce its holdings by no more than 29.38 million shares [1] - The actual controller of Perfect World reduced its stake by 1.247 million shares during a period of abnormal stock fluctuations [1] Group 6 - A shareholder of Tengya Precision plans to reduce its stake by no more than 3.8 million shares [1]

格隆汇2月9日丨联盛化学(301212.SZ)公布，控股股东联盛集团和一致行动人台州高投计划以集中竞价 交易方式和大宗交易方式减持其持有的本公司股份合计不超过3%。其中，以集中竞价交易方式减持 的，在任意连续90个自然日内，减持股份的总数合计不得超过公司股份总数的1%；通过大宗交易方式 减持的，在任意连续90个自然日内，减持股份的总数合计不得超过公司股份总数的2%。 ...

联盛化学公告，公司控股股东联盛集团及其一致行动人台州高投拟减持其持有的公司股份合计不超过 324万股（占公司总股本比例3%）。 （文章来源：第一财经） ...

证券代码：301212 证券简称：联盛化学 公告编号：2026-002 浙江联盛化学股份有限公司 关于公司控股股东及其一致行动人减持股份预披露的公告 公司控股股东联盛化学集团有限公司及其一致行动人台州市高盛投资合伙企业 （有限合伙）保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 二、本次减持计划的主要内容 1.减持原因：股东自身资金需求。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 浙江联盛化学股份有限公司（以下简称"公司"、"本公司"或"发行人"） 的控股股东联盛化学集团有限公司（以下简称"联盛集团"）及其一致行动人台州 市高盛投资合伙企业（有限合伙）（以下简称"台州高投"）计划自本公告披露之 日起 15 个交易日后的 3 个月内以集中竞价交易方式和大宗交易方式减持公司股份， 具体情况如下： 直接持有本公司股份 57,000,000 股（占公司总股本比例 52.78%）的控股股东联 盛集团和直接持有本公司股份 5,000,000 股（占公司总股本比例 4.63%）的一致行动 人台州高投计划以集中竞价交易方式和大宗交易方式减持其持有的本公 ...

Investment Rating - The industry rating is "Recommended" [3] Core Views - Short-term raw material supply tightness is expected to support nickel prices, with LME nickel spot price reaching $18,630 per ton, up 5.70% from January 16 [1] - The cobalt market is anticipated to see continued price increases due to structural supply tightness, with electrolytic cobalt priced at 438,000 yuan per ton, down 3.74% from January 16 [2][5] - Domestic antimony supply remains tight, providing price support, with antimony ingot prices at 160,500 yuan per ton [6] - Lithium carbonate prices are expected to continue rising, with a market average of 171,100 yuan per ton, up 8.36% from January 16 [8][19] - Supply uncertainties in the rare earth market are expected to support prices, with significant global supply concentration in China [10][20] - Tin prices are supported by overseas supply uncertainties, with LME tin prices at $54,200 per ton, up 9.66% from January 16 [11][21] - Tungsten market supply-demand imbalance is notable, with white tungsten concentrate prices at 535,500 yuan per ton, up 5.93% from January 16 [13][22] - Uranium supply tightness is expected to persist, with global uranium prices at $63.51 per pound [14][15] Summary by Sections Nickel and Cobalt Industry Update - Nickel prices are supported by supply constraints, with Indonesia's nickel mining production quota expected to be reduced to 250-260 million tons [1][16] - Cobalt supply is projected to tighten further, with Congo's export quotas confirmed to extend into 2026 [2][17] Antimony Industry Update - Antimony supply remains tight, with domestic prices expected to rise due to export restrictions and seasonal supply issues [6][18] Lithium Industry Update - Lithium carbonate prices are expected to remain strong due to demand support and supply uncertainties, particularly regarding the recovery of key lithium mines [8][19] Rare Earth Industry Update - The rare earth market is facing supply tightening due to export bans and geopolitical factors, with China maintaining a dominant position [10][20] Tin Industry Update - Tin prices are supported by uncertainties in overseas supply, particularly from Myanmar and Congo [11][21] Tungsten Industry Update - The tungsten market is experiencing a supply-demand imbalance, with prices expected to rise due to limited new supply [13][22] Uranium Industry Update - Uranium prices are supported by ongoing supply tightness and geopolitical factors affecting production [14][15]

Group 1 - The core viewpoint of the news is that Liansheng Chemical has shown significant trading activity with a notable financing balance, indicating high investor interest despite a slight decline in stock price [1] - On January 22, Liansheng Chemical's stock price fell by 1.14%, with a trading volume of 87.32 million yuan and a net financing purchase of 1.49 million yuan [1] - As of January 22, the total financing and securities lending balance for Liansheng Chemical was 68.42 million yuan, with a financing balance of 68.09 million yuan, accounting for 1.96% of the circulating market value, which is above the 90th percentile level over the past year [1] Group 2 - As of September 30, the number of shareholders for Liansheng Chemical was 7,270, a decrease of 16.41% compared to the previous period, while the average circulating shares per person increased by 19.63% to 12,895 shares [2] - For the period from January to September 2025, Liansheng Chemical achieved an operating income of 506 million yuan, representing a year-on-year growth of 18.06%, while the net profit attributable to the parent company was 12.41 million yuan, a decrease of 8.20% year-on-year [2] Group 3 - Since its A-share listing, Liansheng Chemical has distributed a total of 97.52 million yuan in dividends, with 75.38 million yuan distributed over the past three years [3]

Core Viewpoint - Liansheng Chemical has received the High-tech Enterprise Certificate, allowing it to enjoy tax benefits for the next three years [2] Group 1: Company Announcement - Liansheng Chemical announced the receipt of the High-tech Enterprise Certificate from the Zhejiang Provincial Economic and Information Technology Department, Zhejiang Provincial Finance Department, and the State Taxation Administration of Zhejiang Province [2] - This recognition is a renewal of the company's previous High-tech Enterprise Certificate, which had expired [2] Group 2: Tax Benefits - Following the new certification, the company will benefit from a reduced corporate income tax rate of 15% for three consecutive years, specifically for the years 2025, 2026, and 2027 [2]